Clinical diagnosis of chronic mucocutaneous candidiasis in a patient with recurrent staphylococcal infections

Authors

  • Luis Alexis Peláez Yáñez Universidad de Ciencias Médicas de Pinar del Río. Hospital Pediátrico Provincial “Pepe Portilla”, Servicio de Inmunología. Pinar del Río. Cuba Author
  • Odalys Orraca Castillo Universidad de Ciencias Médicas de Pinar del Río. Hospital Pediátrico Provincial “Pepe Portilla”, Servicio de Inmunología. Pinar del Río. Cuba Author
  • Jessica O. Solana Rodríguez Universidad de Ciencias Médicas de Pinar del Río. Hospital Pediátrico Provincial “Pepe Portilla”, Servicio de Inmunología. Pinar del Río. Cuba Author
  • Mayelín García García Universidad de Ciencias Médicas de Pinar del Río. Hospital Pediátrico Provincial “Pepe Portilla”, Servicio de Inmunología. Pinar del Río. Cuba Author
  • Julio Israel Hernández Pacheco Universidad de Ciencias Médicas de Pinar del Río. Hospital Pediátrico Provincial “Pepe Portilla”, Servicio de Inmunología. Pinar del Río. Cuba Author

DOI:

https://doi.org/10.62486/agmu202463

Keywords:

chronic mucocutaneous candidiasis, primary immunodeficiency, recurrent pyodermitis

Abstract

Chronic mucocutaneous candidiasis is a primary immunodeficiency characterized by persistent or recurrent candidal infections of the skin, nails, or mucous membranes. It can be associated with endocrinopathies and autoimmune diseases. A 37-years-old male patient is presented who attended an immunology consultation referred from the dermatology service due to recurrent pyodermitis of several years of evolution; the physical examination also revealed signs of candidiasis in the oral mucosa and lip corners, in the eyelids of both eyes and skin in the abdominal region, which were recurrent, as well as onychomycosis in all toenails. The microbiological study of the pyodermitis lesions showed infection by staphylococcus aureus, and the lesions of the mouth, eyes, abdominal skin and nails showed the presence of Candida albicans. Delayed intradermal skin testing was performed with no T cell response to Candida and Trichophyton antigens. Complementary drugs were indicated to rule out any associated endocrine disorder

References

García P, Aquino L, Vega DC, Ortega F, Arenas R. Candidiasis mucocutánea crónica en un paciente con síndrome poliendrocrino autoinmunitario tipo 1. Med Interna Mex. 2022;38(6):1274,1278.

Santa Elena AM, Pantoja A, Cisneros N, Addine B de la C, Parada ME. Diagnóstico y evolución de un caso de candidiasis mucocutánea crónica. Available from: http://www.cibamanz2020.sld.cu/index.php/cibamanz/cibamanz2020/paper/view/114/81

Venturi P, González A, Carolina AM, Marín C, Angiolini SC, Sotomayor CE. Estudio del perfil Th17 en pacientes pediátricos con candidiasis mucocutánea crónica de la provincia de Mendoza. Arch Alerg e Inmunol Clínica [Internet]. 2022;53:145,156. Available from: https://www.researchgate.net/profile/Claudia-Sotomayor-5/publication/378139417_Th17_profile_in_chronic_mucocutaneous_candidiasis_pediatric_patients_in_Mendoza_province/links/65c8e6cb1e1ec12eff81acac/Th17-profile-in-chronic-mucocutaneous-candidiasis-pediat

Ramírez BG, Sáez de Ocaris M del M. Aspectos diagnósticos, fisipatológicos y clínicos de la candidiasis mucocutánea crónica. Revisión de la literatura [Internet]. 2011. Available from: http://repositorio.pediatria.gob.mx:8180/hadle/20.500.12103/1175

Egri N, Esteve-Solé A. Deyà-Martínez À, Ortiz de Landazuri I, Vlagea A, García AP. Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches. Rev Allergol Immunopathol (Madr). 2021;49(1):118-27. DOI: https://doi.org/10.15586/aei.v49i1.20

Chimenez R, Tropeano A, Chirico V, Ceravolo G, Salpietro C, Cuppari C. IL-17 serum level in patients with chronic mucocutaneous candidiasis disease. Rev Pediatr Allergy Immunol. 2022;33(27):77-9. DOI: https://doi.org/10.1111/pai.13636

Chávez MC, Marcelo JL, Gómez Y, González A, Pérez T. Candidiasis mucocutánea crónica. A propósito de un caso. Revista cubana de hematología, inmunología y hemoterapia. 2017;36(suplemento):1-6.

Flores C, Bonifaz A. Aspectos inmunológicos de la candidosis mucocutánea crónica. Dermatología Cosmética, Médica y Quirúrgica [Internet]. 2020;18(4):296–305. Available from: https://www.medigraphic.com/pdfs/cosmetica/dcm-2020/dcm204l.pdf

Blanco Lobo P, Lei WT, Pelham SJ, Guisado Hernández P, Villaoslada I, de Felipe B. Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant. Rev Pediatr Allergy Immunol. 2021;32(8):1804-12. DOI: https://doi.org/10.1111/pai.13603

Ostadi V, Sherkat R, Migaud M, Modaressadeghi SM, Casanova JL, Puel A. Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis. Rev Med Mycol. 2021;59(2):180-8. DOI: https://doi.org/10.1093/mmy/myaa043

Carey B, Lambourne J, Porter S, Hodgson T. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1. Rev Oral Dis. 2019;25(3):684-92. DOI: https://doi.org/10.1111/odi.12881

Baghad B, Benhsaien I, El Fatoiki FZ, Migaud M, Puel A, Chiheb S. [Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections]. / Candidosecutanéo-muqueusechronique avec mutation gain-de-fonction du gène STAT1 associée à des infections herpétiqueset à mycobactérie. Ann Dermatol Venereol. 2020;147(1):41-5. DOI: https://doi.org/10.1016/j.annder.2019.09.597

Frías MG, Rodríguez AC, Torres OU, Acosta G, Martínez E. Epidemiological data of candidiasis in a tertiary hospital in the State of Mexico. Dermatol Rev Mex. 2020;64(2):109-14.

García M, Pérez HF, Rojas CM, León X, Llausás E, García C. Chronic mucocutaneous candidiasis associated with autoimmunity and ectodermal dysplasia. A case report. Rev Alerg Mex. 2021;68(2):144-9. DOI: https://doi.org/10.29262/ram.v658i2.862

Fierabracci A, Arena A, Toto F, Gallo N, Puel A, Migaud M. Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients. Rev J Endocrinol Invest. 2021;44(4):661-77. DOI: https://doi.org/10.1007/s40618-020-01376-5

Candelo PA, Arias DA, Victoria J. Candidiasis mucocutánea generalizada en una paciente con sindrome poliglandular tipo 1. A propósito de un caso. Rev Argentina Dermatología [Internet]. 2019;100. Available from: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-300X2019000300101

Tangye SG, Al W, Aziz H, Charlotte B, Rundles C, Luis J. Human Inborn Errors of Immunity : 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee Internet. Journal of Clinical Immunology. Springer US; 2022. 1473-1507 p. Available from: https://doi.org/10.1007/s10875-022-01289-3. DOI: https://doi.org/10.1007/s10875-022-01289-3

Verda S, Mirza D, Mallory L, MD Z, Steven R. Inmunidad al error innato de la vía inmunitaria Th17 asociada con la candidiasis mucocutánea crónica: una revisión sistemática. Rev Medicam en dermatología. 2023;22:1197–203.

Jobim M, Puel A, Ewald G, Gil BC, Migaud M, Fagundes IS, et al. Nova mutação no gene STAT1 associada com candidíase mucocutânea crônica. Arq Asmas Alerg e Imunol. 2020;4(3):354–9. DOI: https://doi.org/10.5935/2526-5393.20200054

Chebli de Abreu, Nathalia Duarte S, Hyllo MJ, Neto A. Caso para el diagnóstico. Placas eritematosas y descamativas diseminadas: candidiasis mucocutánea crónica. Sci Direct [Internet]. 2023;98:691–4. Available from: https://www.sciencedirect.com/science/article/pii/S0365059623001101?via%3Dihub

Published

2024-09-04

How to Cite

1.
Peláez Yáñez LA, Orraca Castillo O, Solana Rodríguez JO, García García M, Hernández Pacheco JI. Clinical diagnosis of chronic mucocutaneous candidiasis in a patient with recurrent staphylococcal infections. Multidisciplinar (Montevideo) [Internet]. 2024 Sep. 4 [cited 2025 Aug. 20];2:63. Available from: https://multidisciplinar.ageditor.uy/index.php/multidisciplinar/article/view/63